Status:
COMPLETED
Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
Lead Sponsor:
Sir Charles Gairdner Hospital
Conditions:
End Stage Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study aims to examine the effect of 25 hydroxyvitamin D supplementation and a structured exercise program on the exercise capacity and quality of life of haemodialysis patients with 25 hydroxyvit...
Eligibility Criteria
Inclusion
- Stable on dialysis for at least 3 months
- Able to obtain informed consent
- Medically stable
- Dialysis adequacy at target for small solute clearance (ie Kt/V\>1.2 or Urea reduction ratio\>65%)
- Serum 25-hydroxyvitamin D levels less than 75nmol/L at baseline
Exclusion
- Limb Amputation
- Impaired cognition
- Impaired vision
- Haemoglobin concentration \< 110g/L
- Change in Erythropoiesis stimulating agent dose over the last 2 months
- Unable or unwilling to comply with exercise program
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00798993
Start Date
January 1 2009
End Date
September 1 2011
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia, 6009